What type of study is this?

This is a In Vitro Study study (also classified as: Pre-Registered Trial).

What question did this study set out to answer?

This research aims to explore immune features and therapeutic strategies in natural killer T-cell lymphoma through single-cell profiling.

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Single-cell analysis identifies immune characteristics and therapeutic strategies in non-Hodgkin lymphoma, suggesting tailored treatment approaches.

This research aims to explore immune features and therapeutic strategies in natural killer T-cell lymphoma through single-cell profiling.
Conducted scRNA-seq analysis on 63 samples from patients and healthy controls
Identified four distinct subgroups in NKTCL associated with specific immune characteristics
Validated findings through spatial transcriptomics and other omics approaches
Proposed tailored therapeutic strategies under clinical investigation based on the immune profiles
Characterized the immune landscape of NKTCL with distinct clinical outcomes
Identified four subgroups linked to immune exhaustion, desert, exclusion, and TLS enrichment
Proposed targeted therapies, including immune checkpoint inhibitors and epigenetic regulators
Highlighted the association of hemophagocytic lymphohistiocytosis with aggressive disease course

Xia et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Single-cell analysis identifies immune characteristics and therapeutic strategies in non-Hodgkin lymphoma, suggesting tailored treatment approaches.